Menopausal facial erythema and flushing successfully treated with broadband light and botulinum toxin: a case report

Abstract

In menopausal patients, transient facial flushing may lead to persistent erythema and telangiectasias, causing psychological distress and a poor quality of life. Hormonal therapy is the primary treatment for menopausal symptoms, but its use remains limited due to the increased risk of cardiovascular and thromboembolic events. Nonhormonal therapies focus on lifestyle modifications, and energy-based devices have not been sufficiently evaluated. This case report describes the treatment given to a 52-year-old female presenting with menopausal facial erythema and flushing who received a combination of broadband light and intradermal botulinum toxin injections. This case highlights the need for further research that compares various energy-based modalities and their efficacy with established pharmacological treatments for menopausal flushing.